Journal
F1000Research
Publication Date
1-1-2024
Volume
13
First Page
1072
Document Type
Open Access Publication
DOI
10.12688/f1000research.151963.2
Rights and Permissions
Schweiger A, Diniz B, Nicol G et al. Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2025, 13:1072 (https://doi.org/10.12688/f1000research.151963.2) First published: 19 Sep 2024, 13:1072 (https://doi.org/10.12688/f1000research.151963.1) Latest published: 05 Mar 2025, 13:1072 (https://doi.org/10.12688/f1000research.151963.2) Copyright: © 2025 Schweiger A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Schweiger, Abigail; Diniz, Breno; Nicol, Ginger; Schweiger, Julie; Dasklakis-Perez, Andes E; and Lenze, Eric J, "Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 2; peer review: 1 approved, 2 approved with reservations]." F1000Research. 13, 1072 (2024).
https://digitalcommons.wustl.edu/oa_4/6594
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
